25
Participants
Start Date
January 29, 2018
Primary Completion Date
December 13, 2021
Study Completion Date
February 8, 2024
Methylphenidate Pill
Oral methylphenidate (60 mg) given 30 minutes prior to bolus \[11C\]raclopride
Oral Placebo
Oral PL will be given 30 minutes prior to bolus \[11C\]raclopride injection
Intravenous Placebo
Intravenous Placebo given 30 minutes post bolus injection of \[11C\]raclopride.
Intravenous methylphenidate
Intravenous methylphenidate 0.25 mg/kg in 3ml sterile saline given 30 minutes post bolus injection of \[11C\]raclopride.
National Institutes of Health Clinical Center, Bethesda
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH